Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinghui Zhao

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Leukemia|April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpointsYunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Blood|June 29, 2012
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cellsYue Zhang, Xiaomei Yan, Goro Sashida, et al.
Blood|January 23, 2014
Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewalXinghui Zhao, Aili Chen, Xiaomei Yan, et al.
Translational Lung Cancer Research|March 15, 2021
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verificationBo Jia, Xinghui Zhao, Di Wu, et al.
Journal of Biomolecular Screening|October 9, 2012
Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell lineXinghui Zhao, Zhanzhong Zhao, Junwei Guo, et al.
Cancer Cell International|December 10, 2020
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patientsBo Jia, Zhi Dong, Di Wu, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Leukemia|April 11, 2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpointsYunzhu Dong, Xinghui Zhao, Xiaomin Feng, et al.
Blood|June 29, 2012
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cellsYue Zhang, Xiaomei Yan, Goro Sashida, et al.
Blood|January 23, 2014
Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewalXinghui Zhao, Aili Chen, Xiaomei Yan, et al.
Translational Lung Cancer Research|March 15, 2021
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verificationBo Jia, Xinghui Zhao, Di Wu, et al.
Journal of Biomolecular Screening|October 9, 2012
Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell lineXinghui Zhao, Zhanzhong Zhao, Junwei Guo, et al.
Cancer Cell International|December 10, 2020
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patientsBo Jia, Zhi Dong, Di Wu, et al.
Cancer Discovery|August 25, 2018
Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic SyndromesYoshihiro Hayashi, Yue Zhang, Asumi Yokota, et al.
Pageof 5